SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-014283
Filing Date
2020-01-24
Accepted
2020-01-24 16:48:09
Documents
12
Period of Report
2020-01-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d863925d8k.htm   iXBRL 8-K 23846
  Complete submission text file 0001193125-20-014283.txt   149660

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hznp-20200123.xsd EX-101.SCH 3085
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20200123_lab.xml EX-101.LAB 18840
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20200123_pre.xml EX-101.PRE 11849
8 EXTRACTED XBRL INSTANCE DOCUMENT d863925d8k_htm.xml XML 3648
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 20546078
SIC: 2834 Pharmaceutical Preparations